Best Denial Management and AR Recovery Partners

Published on October 7, 2026 by Services Tech Review Editorial Team

Denial prevention, denial management, and legacy AR recovery are three distinct services, and buying the wrong one is one of the most common and costly mistakes revenue cycle leaders make. This guide compares ten leading vendors across all three categories, evaluating denial category scope, payer mix capability, appeals depth, pricing models, delivery infrastructure, and technology claims. The right partner depends on your denial mix, provider size, and whether your need is a one-off legacy AR liquidation project or an ongoing function. There is no single winner, but there is a right fit for your situation.

---

Why Denial Management, AR Recovery, and Denial Prevention Are Not the Same Thing

These three services are often marketed interchangeably, but they address fundamentally different problems in the revenue cycle. Conflating them leads organizations to sign contracts that solve the wrong problem, and to measure the wrong outcomes.

The Three Distinct Jobs: Understand Before You Buy

• Denial Prevention: Front-end eligibility verification, prior authorization, coding and documentation integrity, and clean-claim-rate improvement. The goal is to stop denials before they are issued. A vendor strong here works upstream, at patient access and coding, not at the clearinghouse or the appeals desk.
• Denial Management: Working, appealing, and overturning denials that payers have already issued. This includes technical and administrative denials, clinical and medical-necessity denials requiring physician advisors, DRG downgrade defense, underpayment recovery, and workers' comp or motor vehicle accident claims. A vendor strong here has specialized clinical, legal, and coding expertise deployed against existing denial inventory.
• AR Recovery and Legacy AR Wind-Down: Recovering aged receivables, often post-system-conversion or post-merger, typically worked on contingency. This is a defined-term project with a finite inventory, not an ongoing function. A vendor strong here brings AI-prioritized work queues, payer-behavior analytics, and the operational capacity to close a legacy book without disrupting the current billing environment.

A vendor can excel at one of these jobs and be genuinely weak at the others. The sections below make that distinction explicit for every provider covered.

---

What to Look for in Denial Management and AR Recovery Partners

Buyers who evaluate vendors only on top-line recovery claims tend to miss the structural questions that predict whether an engagement will actually perform. Revenue cycle leaders, CFOs, and practice administrators should weigh the criteria below carefully before issuing an RFP or signing a contract.

Key Evaluation Criteria for Denial Management and AR Recovery Partners

• Denial Category Scope: Does the vendor handle clinical and medical-necessity denials with actual physician advisors and clinical review staff? Or does their capability concentrate on technical and administrative denials, which are easier to work but represent a different segment of your denial mix? Do they handle underpayments and contract-variance recovery, and complex claims such as workers' comp, motor vehicle accidents, VA, and TRICARE?
• Payer Mix Capability: Medicare Advantage denial behavior, appeals ladders, and timely-filing rules differ materially from commercial payer behavior. Medicaid and managed Medicaid add further complexity by state. VA and TRICARE require separate expertise. Verify which payer types the vendor has demonstrable experience with, not just which payer types they list on a capability slide.
• Appeals Depth: Does the vendor handle peer-to-peer reviews, external independent review organization (IRO) appeals, and arbitration? Or do they stop at first-level appeal letters? The difference is material for clinical denials and DRG downgrades, where the high-value recovery often happens at escalation.
• Pricing Model and Incentive Alignment: Contingency-based pricing aligns incentives on high-dollar claims but can create misaligned incentives on small-balance claims, where the vendor's return may not justify effort. FTE or per-claim models shift risk to the provider but guarantee effort on all account sizes. Hybrid models blend both. Ask explicitly what the vendor's small-balance threshold is and what happens to claims they deem unworkable.
• Systems and Integration: Which EHR and billing systems does the vendor actually work in, Epic, Oracle Cerner, Meditech, athenahealth, eClinicalWorks, NextGen, and do they work within your system or require an extract? Working inside your system creates real-time visibility; extract-based models introduce lag and version-control risk.
• Delivery Model: Onshore staff can make live payer calls with fewer escalation barriers. Offshore and hybrid delivery reduces cost but may face restrictions on direct payer contact for certain call types. Know what you are buying.
• AI and Automation, Where Claims Should Be Scrutinized: Automation genuinely helps with denial classification, propensity-to-overturn scoring, autonomous appeal letter assembly for high-frequency denial types, and work-queue prioritization. It does not replace the clinical judgment required for complex medical-necessity denials or the legal reasoning required for arbitration-track appeals. Treat AI marketing claims skeptically and ask for validation data tied to your payer mix and claim type.
• Reporting and Root-Cause Feedback: A recovery total is not a report. Useful reporting traces each denial category back to a root cause, registration, coding, authorization, clinical documentation, and feeds that data upstream into prevention. Ask to see example reports, not just dashboard screenshots.
• Implementation Timeline and Inventory Handoff: What is the mobilization period before the vendor begins working claims? How is the inventory transferred, and what safeguards exist against timely-filing and appeal-deadline risk during the transition? Who owns the deadline risk?
• Legacy AR as a Defined-Term Project: Not all vendors offer AR wind-down as a discrete project. Some only provide ongoing BPO. If your need is a one-time legacy AR liquidation, post-conversion, post-acquisition, or as a backlog clearance, confirm the vendor has a defined-term project structure with milestone-based reporting.

---

Diligence Questions Buyers Routinely Skip

Beyond the standard capability questions, revenue cycle leaders should ask every shortlisted vendor the following before signing:

• What happens to claims the vendor deems unworkable? Are they returned, written off with your authorization, or simply closed? Who has write-off authority and at what balance threshold?
• Who owns the payer relationship during the engagement? Who makes the call on a peer-to-peer? Who controls the appeal narrative if a case escalates to arbitration?
• How are timely-filing and appeal-deadline risks managed during the inventory handoff period? What contractual protections exist if a deadline is missed during transition?
• How is vendor performance measured and held to account? Are there SLAs with financial consequences, or only reporting with no teeth?
• A Business Associate Agreement (BAA) is required before any vendor accesses protected health information (PHI). HIPAA accountability remains with the covered entity and cannot be outsourced along with the work. Confirm BAA terms before any data is shared.

Note: payer contracts, appeal rights, and filing deadlines vary by payer, state, and plan. This guide is not legal, coding, or compliance advice. Verify pricing, ownership, and service lines directly with each vendor before publishing or contracting, this sector consolidates frequently.

---

How Revenue Cycle Leaders Use Denial Management and AR Recovery Partners

Organizations engage denial management and AR recovery partners across a range of operational contexts. Understanding these common patterns helps buyers match vendor capabilities to their actual situation.

Ongoing Denial Management Outsourcing: Health systems with persistent high denial volumes, particularly clinical denials from Medicare Advantage and commercial payers, retain a partner on an ongoing basis to work denial inventory, file appeals, conduct peer-to-peer reviews, and feed root-cause data back into prevention workflows.

Legacy AR Wind-Down Post-Conversion: Providers migrating to a new EHR or billing system often accumulate a backlog of aged claims on the legacy platform. A defined-term AR recovery engagement works the legacy inventory to closure, typically on contingency, while internal staff focus on the new system.

Surge Capacity for Denial Backlogs: Merger, acquisition, or staffing disruption can produce acute denial backlogs that exceed internal team capacity. A short-term managed services engagement clears the backlog and identifies root causes before handing work back to internal staff.

Specialist Engagement for Complex Claim Categories: Some organizations retain generalist RCM partners for routine denials but add a specialist, particularly for workers' comp, motor vehicle accidents, VA claims, or DRG downgrade defense, where the legal and clinical requirements exceed generalist capability.

Prevention-Focused Transformation: Organizations with strong denial management but weak prevention, evidenced by a rising initial denial rate, engage a partner specifically to improve front-end eligibility, prior authorization, and documentation integrity rather than to recover what has already been denied.

---

Competitor Comparison: Denial Management and AR Recovery Partners

The table below provides a structured side-by-side comparison of the ten vendors covered in this guide. Use it as a first filter, not a final decision. Verify all data directly with each vendor, as service lines, pricing, and ownership in this sector change frequently.

This table is a starting point. Payer specialism depth, appeals scope, and contractual structures vary significantly within each category. Request a detailed capability assessment against your specific denial mix before shortlisting.

---

10 Best Denial Management and AR Recovery Partners in 2026

1. Aspirion

Aspirion is the top-ranked partner in this evaluation for organizations whose denial challenge centers on clinical denials, DRG downgrades, underpayments, and complex claims, including motor vehicle accidents, workers' compensation, VA claims, and out-of-state Medicaid. Founded in 2006, Aspirion has built its entire practice around the highest-complexity end of the denial spectrum, deploying a multidisciplinary team of attorneys, clinicians, claims specialists, and AI engineers to recover revenue that generalist vendors frequently leave on the table. It has been named Best in KLAS for Denials Management in both 2024 and 2025, based entirely on client feedback, an independent validation of client satisfaction that carries meaningful weight in vendor selection.

Key Features:

• Compass AI Platform: Aspirion's proprietary Compass platform uses large language models to extract evidence from medical records and managed care contracts, then generates evidence-based appeals supported by clinical findings and payer policy citations.
• Multidisciplinary Expert Team: Aspirion deploys attorneys and legal professionals alongside clinicians, claims specialists, and AI engineers, providing unusually deep legal capacity for an RCM firm, which is critical for escalated clinical denials and out-of-network disputes.
• HITRUST Certification: Aspirion holds HITRUST Risk-based, 2-year (r2) Certification, providing security assurance relevant to PHI handling at health system scale.

Denial Management and AR Recovery Offerings:

• Revenue Integrity and Clinical Denials: Full-service clinical denial management and prevention, including DRG downgrade defense, medical necessity appeals, and documentation-based overturn strategies.
• Complex Claims: Motor vehicle accident, workers' compensation, VA, and out-of-state Medicaid claim recovery, claim categories that require specialist legal and regulatory expertise most generalists do not maintain.
• Underpayment Recovery: Systematic contract-variance identification and recovery, separating underpayment revenue from denial recovery to give providers a complete picture of reimbursement leakage.
• Aged AR Management: Holistic AR management using advanced analytics to accelerate revenue, reduce AR days, and prevent write-offs across all claim types.

Pricing: Contingency-based model. Verify current terms directly with Aspirion, as pricing structures in this sector are subject to change.

Pros:

• Consecutive Best in KLAS recognition (2024 and 2025) based solely on client feedback provides independent performance validation.
• Unusually deep legal and clinical expertise for complex clinical denials, DRG downgrades, and out-of-network escalations.
• Compass platform integrates AI-powered appeal generation with clinical and contract evidence extraction.
• Strong coverage of complex claim categories, MVA, workers' comp, VA, that are outside most generalists' core competency.
• HITRUST certification supports security requirements for large health system engagements.
• Onshore-led team reduces barriers to live payer calls and clinical escalation.

Cons:

• Specialist model: the highest value is in complex clinical and high-dollar denial categories. Organizations with predominantly technical or administrative denial volumes may find a generalist partner more cost-efficient for that workload segment.
• Not typically structured for full-cycle RCM outsourcing. Organizations seeking to hand off the entire revenue cycle need to pair Aspirion with a broader BPO partner for front-end and routine claim functions.

Aspirion's specialist positioning is its defining strength and the primary reason it leads this evaluation. Organizations that have already contracted with a generalist RCM vendor and are still losing revenue on clinical denials, DRG downgrades, and complex claim categories should evaluate Aspirion specifically for those segments, either as a standalone engagement or as a specialist layer alongside an existing partner. Its combination of Best in KLAS recognition, attorney-supported appeals, Compass platform, and complex claim coverage represents the deepest capability set in the denial management category.

---

2. R1 RCM

R1 RCM is one of the largest revenue cycle management companies in the United States, serving hospitals, health systems, and physician groups with a full-cycle model that spans prevention, denial management, and AR recovery. R1 processes significant patient revenue volumes annually across its client base. In 2026, R1 launched R1 AR Recovery and R1 Denial Management as distinct product lines within its Phare Operating System, positioning the company to serve providers who need point-solution recovery alongside those who have broader RCM outsourcing relationships.

Key Features:

• Phare Operating System: R1's agentic AI platform designed to deploy AI-assisted workflows across the revenue cycle, covering AR recovery, denial management, and prior authorization.
• Full-Cycle RCM Scope: R1 manages the revenue cycle from pre-registration and financial clearance through coding, billing, denials management, and underpayment recovery.
• Clinical and Attorney-Level Denial Staff: R1's denials management solution is staffed by experienced clinicians, attorneys, certified coders, and reimbursement analysts.

Denial Management and AR Recovery Offerings:

• R1 Denial Management: AI-assisted workflows for appeal acceleration, denial reduction, and recovery across clinical, technical, and administrative denial categories.
• R1 AR Recovery: Technology and AI-assisted expert combination targeting AR reduction and cycle-time improvement across all payers.
• Prior Authorization: Comprehensive prior authorization management as a defined solution within the Phare platform.
• Underpayment Recovery: Identification and recovery of underpaid commercial, government, and managed care claims.

Pricing: Managed services model; hybrid performance-based structures available. Verify current pricing directly with R1, as this sector's commercial terms evolve frequently.

Pros:

• Scale and breadth across the full revenue cycle, from prevention through recovery, with a single operating platform.
• Phare OS integrates AI-assisted workflows with human clinical and legal expertise for denial management and AR recovery.
• Deep institutional experience with hospital-scale claim volumes and complex payer environments.
• Flexible engagement model supporting both full-cycle BPO and point-solution deployments.

Cons:

• Enterprise orientation may make R1 less agile for smaller physician groups or ambulatory settings without significant volume.
• Organizations with isolated complex-claim categories, workers' comp, MVA, VA, may find specialist vendors more targeted than a broad RCM platform for those segments.
• Phare OS is in active deployment with select clients; buyers should verify live rollout scope and applicable client types before contracting.

---

3. Ensemble Health Partners

Ensemble Health Partners manages end-to-end revenue cycle operations for health systems, including more than 200 hospitals nationwide, spanning patient access, coding, claims management, denial prevention, accounts receivable follow-up, and the patient financial experience. Its model is built for health systems that want to outsource most or all of the revenue cycle to a single partner, with denial management embedded in the broader operating structure rather than delivered as a separate project. Ensemble's proprietary EIQ platform reads the medical record in real time to flag denial risk before claims are submitted, placing genuine prevention capability at the core of the model.

Key Features:

• EIQ Analytics Platform: Ensemble's proprietary revenue cycle intelligence engine identifies denial risk within existing workflows, flags payment anomalies, and drafts denial appeals using generative AI with clinical oversight.
• Generative AI for Appeals: Ensemble reports 40% faster denial appeal submissions and a 100% clinical review success rate for appeal letters crafted by its generative AI, according to published performance metrics.
• Cross-Client Benchmarking: Ensemble's scale across managed revenue gives it pattern-recognition capability across payer behavior and denial trends that no single health system could develop internally.

Denial Management and AR Recovery Offerings:

• Clinical Denial Prevention: EIQ reads medical records and identifies denial risk with actionable recommendations inside existing workflows, specifically designed for clinical denials in large health system environments.
• Denial Management: Root-cause analysis, appeal workflow automation, and specialist staff handling technical, administrative, and clinical denials.
• Prior Authorization: AI-powered prior authorization denial prediction and prevention, with pilot results showing a 30% reduction in outpatient prior authorization denials.
• AR Follow-Up: Accounts receivable management embedded within the central business office model.

Pricing: Incentive-based managed services model. Pricing is bundled into the broader outsourcing engagement. Verify current commercial terms directly with Ensemble.

Pros:

• End-to-end outsourcing model provides integrated visibility across the revenue cycle, enabling Ensemble to trace denials back to registration or coding root causes.
• EIQ platform provides genuine front-end prevention capability, not just back-end recovery.
• Strong track record with large health systems seeking full central business office outsourcing.
• Modular engagement option allows organizations to start with coding or denials before committing to full outsourcing.

Cons:

• Built for health systems. Ambulatory, digital health, and smaller physician group organizations fall below Ensemble's typical engagement profile.
• Full outsourcing transfers operational control to Ensemble. Organizations that want to retain internal management of staff and workflows should evaluate carefully before committing.
• Primarily a health-system outsourcing model rather than a specialist denial or complex-claims recovery firm.

---

4. Savista

Savista is an end-to-end revenue cycle services provider with more than 35 years of experience supporting hospitals, health systems, and physician practices. With over 800 clients across 49 states and an HFMA Peer Reviewed designation, Savista integrates directly with clients' existing EHR systems rather than requiring new technology platforms. Its denial management capability centers on clinical denials, medical necessity, DRG downgrades, no-authorization denials, staffed by RN-led clinical appeal teams and supported by root-cause reporting that feeds back into prevention.

Key Features:

• RN-Led Clinical Appeal Writing: Savista's denial management team includes registered nurses and clinicians who write clinical appeals for medical-necessity, level-of-care, and DRG downgrade denials.
• Root-Cause Analysis and Prevention: Root-cause identification and physician and staff education to reduce initial denial rates over time.
• Experience Across PAS and EMR Systems: Savista's workforce integrates directly with clients' existing systems, covering all major patient accounting and EMR platforms.

Denial Management and AR Recovery Offerings:

• Clinical Denial Management: Full-service resolution of clinical denials including medical necessity, DRG downgrades, and authorization-related denials.
• AR Management: Accounts receivable management services with $6 billion in AR collections annually across the client base.
• HIM and Coding: Health information management and coding services supporting documentation integrity and front-end denial prevention.
• TPE Audit Defense: Savista reports a 100% success rate on Targeted Probe and Educate (TPE) audits, per published outcomes.

Pricing: Flexible workforce options including managed services and dedicated team models. Verify current pricing directly with Savista.

Pros:

• Long operational history and broad client base provide payer pattern depth across commercial, Medicare, and Medicaid.
• RN-led appeals provide clinical credibility for medical-necessity and level-of-care denials.
• EHR-agnostic integration model reduces implementation friction.
• HFMA Peer Reviewed designation supports credibility with compliance-focused buyers.

Cons:

• Savista's model is workforce-led rather than technology-native; organizations seeking an AI-forward platform as the primary delivery mechanism should evaluate accordingly.
• Deep specialism in complex claim categories such as MVA, workers' comp, and VA is not a published core strength.
• Specialist denial vendors may offer deeper capability for high-complexity clinical denial escalation.

---

5. Conifer Health Solutions

Conifer Health Solutions, a Tenet Healthcare subsidiary, provides full-cycle revenue cycle management and value-based care services to hospitals, health systems, and physician groups. In February 2026, Tenet regained full ownership of Conifer after CommonSpirit Health exited its minority stake. Conifer's denial management capability is embedded within its A/R management outsourcing model, covering clinical, technical, and administrative denials, underpayments, and self-pay. The proprietary ConiferCore Revenue Performance platform and automated first-level technical appeals provide operational depth for large-scale health system engagements.

Key Features:

• ConiferCore Revenue Performance Platform: Conifer's proprietary platform supports denial workflow automation, predictive analytics, and payer scoring for denial prevention and management.
• Automated First-Level Technical Appeals: Conifer reports over 133,000 automated first-level technical appeals, reducing manual effort on high-frequency denial types.
• Google Cloud AI Collaboration: Conifer has announced a collaboration with Google Cloud to embed advanced AI across its RCM operations, signaling continued investment in automation.

Denial Management and AR Recovery Offerings:

• Clinical, Technical, and Administrative Denial Management: Full-spectrum denial coverage with licensed clinical staff handling all levels of appeals.
• Underpayment Recovery: Clinical and technical underpayment identification and appeal.
• Government Audit Defense: Reviews and appeals for RAC, MAC, and other government audit programs.
• Self-Pay and Bad Debt Recovery: Patient liability follow-up and bad debt recovery using MicroSegmentation technology.

Pricing: Managed services model, bundled into full-cycle outsourcing engagements. Verify current terms directly with Conifer.

Pros:

• Broad full-cycle outsourcing capability with denial management as an embedded service, not an add-on.
• Established track record with large hospital systems requiring a single outsourcing partner for the entire mid-to-back-end revenue cycle.
• Automated technical appeal workflows reduce cost-to-collect on high-frequency denial types.

Cons:

• Conifer's model is most efficient for health systems aligned with or similar to Tenet-affiliated provider structures. Independent health systems should verify fit carefully.
• Sector consolidation around Tenet's repurchase creates ownership transition risk worth monitoring before multi-year contract commitments.
• Complex specialist claim categories, workers' comp, MVA, VA, are not a published primary focus.

---

6. Knowtion Health

Knowtion Health, formerly RSource Healthcare, is a specialist revenue cycle firm focused entirely on problem claims and complex financial classes for hospitals and health systems. Backed by Arsenal Capital Partners following a 2024 acquisition, Knowtion serves more than 500 hospitals nationwide. Its service scope spans clinical denials, coordination of benefits and patient-involvement denials, low-balance recovery, complex claims including MVA and VA, and payer audit defense, a combination that positions it as a strong fit for health systems whose denial challenge spans multiple claim categories, not just clinical or just technical.

Key Features:

• Breadth of Specialist Services: Knowtion covers clinical denials, COB resolution, low-balance recovery, VA claim recovery, and payer audit defense within a single engagement structure.
• AI-Enabled Platform: Purpose-built AI platform supporting claim prioritization, denial resolution, and revenue optimization across multiple claim types.
• SOC 2 Certification: SOC 2 assessment conducted by A-LIGN supports compliance and data security requirements.

Denial Management and AR Recovery Offerings:

• Clinical Denials: Management and overturn of medical-necessity and authorization denials, including physician-level review.
• COB and Patient-Involvement Denials: Resolution of coordination-of-benefits denials and patient-involved claim issues, including direct patient engagement.
• Complex Claims: MVA, VA, third-party liability, and workers' compensation recovery.
• Low-Balance Recovery: Specialist low-balance account recovery with automated workflows.
• Payer Audit Defense: Defense against payer-initiated audits, a capability not universally offered by generalist denial management vendors.

Pricing: Contingency-based model. Verify current terms directly with Knowtion.

Pros:

• Specialist breadth across multiple problem-claim categories that broader RCM vendors may not work with equivalent depth.
• Payer audit defense capability differentiates Knowtion from vendors focused purely on denial recovery.
• Onshore delivery model supports direct payer call capability without offshore barriers.
• Strong hospital and health system client base with established operational track record.

Cons:

• Smaller firm than enterprise-scale BPO competitors; health systems requiring very large-volume full-cycle outsourcing should verify operational capacity.
• Not positioned as a full prevention or front-end eligibility partner; buyers with heavy prevention needs should evaluate accordingly.
• Ownership transition following the Arsenal Capital acquisition warrants verification of leadership continuity and service-line stability before contracting.

---

7. Infinx

Infinx is a technology-led revenue cycle management company offering a platform, the ARDM (A/R Recovery and Denials Management) platform, that combines AI-powered analytics with RCM specialists for denial management, AR recovery, and prior authorization. Its delivery model is offshore-led with onshore oversight, making it structurally cost-competitive for physician groups, specialty practices, and mid-market health systems. Infinx's platform integrates via API, HL7, FHIR, and X12 with a broad range of EHR systems, and the company's stated performance targets for its RCM Plus platform, which covers denial management and AR recovery together, are specific enough to anchor SLA discussions.

Key Features:

• ARDM Platform: AI and automation-driven accounts receivable and denial management platform that prioritizes claims by recovery probability, automates follow-up, and provides analytics across payer behavior and denial trends.
• Bi-Directional EHR Integration: Integration with Epic, athenahealth, eClinicalWorks, Salesforce, and others via API or HL7, supporting real-time claim status and workflow automation.
• Healthcare Revenue OS: Infinx's platform architecture designed to serve as connective tissue across patient access, prior authorization, mid-cycle coding, and back-end denial management and AR recovery in a single engagement.

Denial Management and AR Recovery Offerings:

• A/R Recovery and Denials Management (ARDM): Combined platform for working aged AR and denied claims, with AI-based recoverability scoring and automated work-queue routing.
• Prior Authorization: AI-powered prior authorization submission, status tracking, and exception handling.
• Revenue Recovery and Denials: End-to-end denial management embedded in broader RCM outsourcing engagements.

Pricing: Per-claim, subscription, and hybrid models depending on engagement scope. Verify current pricing directly with Infinx.

Pros:

• Technology-first platform with genuine AI-based prioritization and automated follow-up reduces cost-to-collect on high-volume denial workloads.
• Broad EHR integration capability minimizes implementation barriers for multi-system environments.
• Cost-competitive delivery model suited to physician groups and mid-market health systems where enterprise BPO pricing is prohibitive.
• Modular engagement allows expansion from prior authorization to denial management to full AR recovery as client confidence builds.

Cons:

• Offshore-led delivery model may face constraints on direct payer calls for complex clinical escalations requiring live U.S.-based clinical dialogue.
• Platform strength is greatest on technical, administrative, and high-volume denial categories; clinical denials requiring deep physician advisory engagement may benefit from a more specialist partner.
• Buyers should stress-test performance targets stated in marketing materials with SLA language tying fees to performance baselines before signing.

---

8. AGS Health

AGS Health is a revenue cycle management company with a workforce of more than 15,000 RCM professionals worldwide, including a nearshore delivery center in Guadalajara, Mexico, alongside India-based operations. AGS Health serves nearly 50% of the 20 most prominent U.S. hospitals and 40% of the nation's 10 largest health systems, according to published company data. Its RCM model combines clinical documentation improvement, medical coding, denial management, and AR management under an integrated hybrid intelligence model, where AI agents handle high-volume workflows and human RCM professionals manage exceptions and strategic direction.

Key Features:

• AGS AI Platform: Includes Intelligent Authorization, Autonomous Coding, and the Intelligent RCM Engine, agentic AI tools designed to handle eligibility verification, prior authorization, denials management, and appeals at scale.
• Hybrid Intelligence Model: Human RCM professionals remain central to strategy, oversight, and accountability, with AI agents managing high-volume tasks and routing exceptions for clinical review.
• Physician Advisory Services: Utilization management and physician advisory capability supporting clinical denial appeals and level-of-care reviews.

Denial Management and AR Recovery Offerings:

• Denial Management and Prevention Services: Resolving denied claims and preventing future denials through root-cause analysis, front-end process improvement, and automated workflows.
• Clinical Denials and Appeals: Clinical denial appeal services covering medical necessity, level-of-care, and authorization denials with physician advisory support.
• A/R Management Services: Aged AR management and underpayment recovery as part of broader patient financial services.
• Payment Variance and Underpayment Recovery: Contract-variance identification and appeal for systematic underpayments.

Pricing: Managed services model; FTE-based and hybrid pricing structures available. Verify current pricing directly with AGS Health.

Pros:

• Large-scale workforce with deep RCM expertise across coding, clinical documentation, and denial management supports high-volume health system engagements.
• Hybrid intelligence model provides AI efficiency with human accountability, a more defensible architecture for complex clinical denial types than pure automation.
• Nearshore delivery in Mexico reduces geographic latency compared with India-only offshore models for real-time payer interactions.
• Strong clinical documentation and coding integration enables upstream prevention alongside downstream denial recovery.

Cons:

• Primary delivery model is offshore and nearshore; organizations with requirements for predominantly onshore staff should verify delivery structure before contracting.
• Complex specialist claim categories, workers' comp, MVA, VA, are not a primary published focus of AGS Health's service portfolio.
• Full-cycle engagement orientation may be more than required for organizations seeking a focused, standalone denial management or AR recovery project.

---

9. CorroHealth

CorroHealth is a healthcare revenue cycle management company offering clinical documentation integrity, coding, AR management, denial management, and specialized AR recovery services. Backed by The Carlyle Group, CorroHealth has expanded its denial management capability through the acquisition of Aergo Solutions, adding clinical, nursing, legal, and contract representation expertise to its appeals infrastructure. Its PRISM Enterprise RCM Technology platform prioritizes claims by payer behavior and reimbursement likelihood, and its REVIVE Specialized RCM platform is built specifically for aged AR recovery as a defined-term engagement.

Key Features:

• PRISM Enterprise RCM Technology: AI-enabled platform that organizes claims by dollar value, complexity, and age, prioritizing workloads for AR management and denial recovery.
• REVIVE Specialized RCM: Aged AR recovery platform designed for defined-term legacy AR wind-down projects, including small balance, zero balance, Transfer DRG, and post-conversion AR portfolios.
• VISION Clinical Validation Technology and PULSE Coding Automation: Integrated technology suite connecting CDI, coding, and AR recovery functions.

Denial Management and AR Recovery Offerings:

• Denials Prevention and Management: Clinical, technical, and administrative denial management using analytics and dedicated clinical, coding, and legal specialists.
• DRG Downgrade Defense: Specialized DRG downgrade appeal capability backed by clinical and regulatory expertise.
• Specialized AR Recovery: Small balance, zero balance, Transfer DRG, and legacy AR recovery using PRISM for claim prioritization.
• Contract Management: Contract-variance identification and denial root-cause analysis feeding back into payer negotiation strategy.

Pricing: Contingency and managed services models available depending on engagement type. Verify current pricing directly with CorroHealth.

Pros:

• REVIVE platform is specifically built for legacy AR wind-down, a defined-term project structure that many competitors do not offer as a discrete engagement.
• PRISM platform provides AI-powered prioritization across large AR portfolios, supporting efficient recovery without proportional staffing scale.
• DRG downgrade defense and specialized AR categories, small balance, zero balance, Transfer DRG, are explicitly covered rather than incidental.
• Aergo acquisition adds clinical, nursing, and legal appeal expertise to the denial management team.

Cons:

• Complex claim categories such as workers' comp, MVA, and VA are not the primary published focus of CorroHealth's denial service lines.
• Full prevention capability, front-end eligibility and prior authorization, is less prominent than its AR recovery and denial management positioning.
• Buyers should verify post-acquisition integration completeness and team stability before contracting, given recent organizational changes.

---

10. Med-Metrix

Med-Metrix is an RCM company founded in 2010, headquartered in Parsippany, New Jersey, offering performance management analytics, consulting, extended business office services, and revenue recovery to hospitals, health systems, and physician groups. Its AI Denials Management platform uses machine learning, large language models, and payer-specific training data to classify denials, predict overturn probability, and generate complete appeal packets. Med-Metrix has grown through strategic acquisitions and maintains operational experience across Epic, Meditech, Allscripts, Oracle Cerner, and other major patient accounting systems.

Key Features:

• AI Denials Management Platform: Proprietary denial AI using machine learning and LLMs to predict overturn probability, classify denials, and automate appeal packet generation with payer-specific letters and clinical documentation.
• Physician Advisory Services: Highly qualified remote physician advisors supporting level-of-care protocols, concurrent denial appeals, and peer-to-peer interventions.
• Multi-System Proficiency: Operational experience across Epic, Meditech, Allscripts, Oracle Cerner, and other major patient accounting systems, with multi-lingual staff.

Denial Management and AR Recovery Offerings:

• Denials Management: Technical, clinical, and administrative denial management with AI-assisted classification, appeal generation, and automated follow-up.
• Payment Variance Recovery: Systematic underpayment and contract-variance identification and recovery.
• Transfer DRG Review: Specialized Transfer DRG claim review and recovery.
• A/R Liquidation: Legacy AR liquidation and safety net recovery for defined-term engagements.
• Complex Claims: Complex claim handling and safety-net financial class management.

Pricing: Contingency and managed services models available. Verify current pricing directly with Med-Metrix.

Pros:

• AI Denials Management platform offers genuine automation across the appeal lifecycle, from inbound correspondence processing through packet generation and follow-up.
• Physician advisory capability supports peer-to-peer interventions and concurrent denial appeals, capabilities not universally available from technology-led vendors.
• Broad EHR system proficiency reduces integration friction for multi-system health system environments.
• Defined-term AR liquidation structure available for legacy AR projects alongside ongoing denial management engagements.

Cons:

• Primarily onshore-led model may carry higher unit costs than offshore or hybrid alternatives for high-volume routine denial categories.
• Scale relative to the largest enterprise BPO vendors means very large health systems should verify operational capacity before contracting.
• AI performance claims, including denial overturn rates, should be verified against the buyer's specific payer mix and denial categories, not accepted as universal benchmarks.

---

Evaluation Rubric for Denial Management and AR Recovery Partners

Revenue cycle leaders and CFOs selecting a denial management or AR recovery partner should evaluate vendors against the weighted criteria below. The relative weight of each criterion will vary by organization, denial mix, and primary use case, a health system running a legacy AR wind-down will weight implementation structure differently than one building an ongoing clinical denial management function.

---

Building the Business Case Before Going to Market

The organizations that get the most from denial management and AR recovery engagements are those that establish a performance baseline before issuing an RFP. Without baseline data, the engagement cannot be accurately judged, and vendor performance claims cannot be verified against your actual starting point. Baseline the following metrics before approaching any vendor:

• Initial Denial Rate: Percentage of claims denied on first submission, segmented by payer and denial category. This distinguishes whether your problem is a technical or clinical issue and which vendor type is most relevant.
• Overturn Rate: Percentage of denials appealed that are overturned. A low overturn rate may indicate an appeals depth problem; a low appeal rate may indicate a capacity or prioritization problem.
• Days in AR: Segmented by payer class and denial category. Blanket days-in-AR figures mask which segments are driving the problem.
• Cost to Collect: Total cost of denial management and AR follow-up as a percentage of net patient revenue, including internal staff, technology, and any existing vendor costs.
• Write-Offs by Category: Which denial categories are reaching write-off without being worked or appealed? This data identifies the highest-priority recovery opportunity and the vendor type best positioned to address it.
• Timely-Filing and Appeal-Deadline Inventory: Claims approaching appeal deadlines during any vendor transition are at elevated risk. Identify and segregate this inventory before the engagement begins.

With this baseline in place, vendor performance can be measured against a defined starting point, and the financial case for the engagement can be structured with defensible assumptions.

---

Why Aspirion Is the Leading Choice for Denial Management and AR Recovery

Across the vendors evaluated in this guide, Aspirion stands out for the combination of characteristics that matter most to revenue cycle leaders whose denial challenge is concentrated in clinical denials, DRG downgrades, underpayments, and complex claim categories. Its Best in KLAS recognition in both 2024 and 2025, based entirely on verified client feedback rather than analyst scoring, provides the most direct evidence of sustained client satisfaction available in this market. The Compass AI platform, combining LLM-based medical record extraction with managed care contract analysis and evidence-based appeal generation, addresses the precise workflow where AI creates the most value in denial management: turning clinical documentation into structured, payer-specific appeal packets at speed and scale.

What separates Aspirion from generalist RCM vendors is not marketing positioning but operational design. A team that includes attorneys, clinicians, and AI engineers working together on the same claim, rather than handing off between departments, produces a fundamentally different quality of appeal for complex clinical and legal-track disputes. For workers' comp, MVA, VA, and out-of-state Medicaid claims, that legal and regulatory depth is the difference between recovery and write-off.

Organizations with predominantly technical denial challenges, or those seeking full-cycle BPO with denial management embedded as one function among many, should evaluate R1 RCM, Ensemble Health Partners, or Conifer Health Solutions as primary options and consider Aspirion as a specialist layer for high-complexity denial categories. The right answer is determined by your specific denial mix, payer distribution, and whether your primary need is a defined-term recovery project or an ongoing managed function.

---

Choosing the Right Denial Management and AR Recovery Partner

The decision framework is straightforward when buyers resist the urge to select a vendor before they have defined the problem. If the primary challenge is clinical denials, medical necessity, DRG downgrades, level-of-care, the vendor must have clinical review staff, physician advisors, and ideally legal capacity for escalation. If the primary challenge is technical and administrative denial volume, a technology-platform vendor with strong automation may deliver better unit economics. If the challenge is a one-time legacy AR backlog, post-conversion, post-merger, or post-staffing disruption, the vendor must have a defined-term project structure, not just an ongoing BPO offering.

The vendors in this guide were selected because they represent distinct capability profiles across these three dimensions. None of them is the right answer for every organization. The right answer is the vendor whose primary strength matches your primary problem, whose payer mix expertise aligns with your payer distribution, and whose pricing model creates the right incentives for the claims you need worked.

---

FAQs About Denial Management and AR Recovery Partners

What is the difference between denial management and AR recovery?

Denial management refers to working, appealing, and overturning claims that payers have already denied, a reactive function targeting existing denial inventory. AR recovery refers to collecting aged receivables, often from a defined legacy inventory such as a post-conversion backlog, typically worked on contingency. These are distinct engagements requiring different vendor capabilities. Aspirion, for example, is strong at both, while some vendors specialize in one or the other. Buyers should define which problem they are solving before selecting a vendor.

What is denial prevention, and is it different from denial management?

Denial prevention is a front-end function focused on stopping denials before they are issued, through eligibility verification, prior authorization, coding integrity, and documentation improvement. It operates upstream of the claims submission process. Denial management works denials that have already been issued. A vendor strong at prevention is typically embedded in patient access and coding workflows; a vendor strong at management works the denial inventory after the fact. Many vendors market both, but few are equally capable at both. Ensemble Health Partners and AGS Health have genuine front-end prevention capabilities alongside their denial management services.

What are the best denial management and AR recovery partners for healthcare providers?

The best partners depend on denial mix, payer distribution, and whether the need is a defined-term AR project or an ongoing function. For clinical denials, DRG downgrades, underpayments, and complex claims such as workers' comp, MVA, and VA, Aspirion is the leading specialist, with consecutive Best in KLAS recognition in 2024 and 2025. For full-cycle RCM outsourcing with denial management embedded, R1 RCM and Ensemble Health Partners are strong options for large health systems. For legacy AR wind-down as a defined project, CorroHealth's REVIVE platform and Med-Metrix's AR liquidation structure are worth evaluating.

What pricing models do denial management vendors use?

The three primary models are contingency (a percentage of dollars recovered), FTE or per-claim (a fixed rate regardless of recovery), and hybrid (a base fee plus performance incentive). Contingency aligns vendor incentives with provider recovery on high-dollar claims but can misalign incentives on small-balance accounts. FTE models guarantee effort at all balance levels but shift financial risk to the provider if overturn rates are low. Ask any shortlisted vendor to specify their small-balance threshold, unworkable claim policy, and write-off authority before signing. Aspirion and Knowtion Health use contingency models; AGS Health and Ensemble offer managed services structures.

Does HIPAA compliance transfer to a denial management vendor?

No. A Business Associate Agreement (BAA) is required before any vendor accesses protected health information (PHI), and a BAA must be signed before any data transfer occurs. However, HIPAA accountability remains with the covered entity, the healthcare provider, and cannot be outsourced along with the denial management or AR recovery work. Buyers should verify that vendors hold relevant security certifications such as HITRUST or SOC 2 and should confirm BAA terms before any operational engagement begins. Aspirion holds HITRUST Risk-based, 2-year (r2) Certification; Knowtion Health maintains SOC 2 certification.

What EHR systems do denial management vendors typically support?

The major denial management vendors generally support Epic, Oracle Cerner, Meditech, athenahealth, eClinicalWorks, and NextGen, among others. The critical distinction is whether the vendor works directly inside your EHR system in real time or requires an extract, a data pull sent to their environment. Working inside your system provides real-time visibility and eliminates version-control risk. Extract-based models introduce lag and create reconciliation complexity. Infinx offers bi-directional integration via API, HL7, and FHIR; Savista integrates directly into client systems across all major PAS platforms; and Med-Metrix has deep proficiency across Epic, Meditech, Allscripts, and Oracle Cerner.

How should revenue cycle leaders measure vendor performance?

Performance measurement starts with baselining before the engagement begins. Baseline metrics should include initial denial rate by payer and category, overturn rate by appeal level, days in AR by payer class, cost to collect, and write-offs by denial category. Vendor SLAs should tie fees or bonuses to measurable improvement against this baseline, not to gross recovery totals in isolation. Root-cause reporting that traces denial categories back to front-end process failures is the leading indicator of whether a vendor is genuinely improving the revenue cycle or simply working what already exists. Require root-cause analytics as a contractual deliverable, not an optional reporting feature.